/Companies

Edenbridge Holdings

New York, US · Founded 2016 · Delaware LLC

Find your way into Edenbridge Holdings

Sign up to see every warm intro you have to Edenbridge Holdings

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Edenbridge Holdings team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JH
James HochExecutive
MR
M. Ryan CollinsExecutiveM. Ryan Collins is an Executive Officer and Director at Edenbridge Holdings with expertise in pharmaceuticals, biopharmaceuticals, and biotechnology.
PC
Patrick ChuExecutive
GS
Geoffrey S. RakerExecutive

Board

FS
Frank SicaBoard director
KC
Kevin ConnellyBoard director
KM
Kamal MarufBoard director
JL
Joseph LearyBoard director

Reported raises · per SEC filings

Form D private placements

$15.4M disclosed across 1 round · 2017

▶$15.4MraisedJan 2017 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank SicaDirector
  • Kevin ConnellyDirector
  • James HochExecutive Officer
  • Kamal MarufDirector
  • M. Ryan CollinsExecutive Officer, Director
  • Joseph LearyDirector
  • Patrick ChuExecutive Officer, Director
  • Geoffrey S. RakerExecutive Officer, Director
Amount sold
$15.4M
First sale
Jan 2017
Incorporated
Limited Liability Company, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Edenbridge Holdings raised?
Edenbridge Holdings has disclosed $15.4M raised across 1 round.
Where is Edenbridge Holdings headquartered?
Edenbridge Holdings is headquartered in New York, US.